vice chair and chair of the Department of Biochemistry and Biophysics of the University of California, San Francisco. Being committed to the improvement of science education, he has dedicated much of his time to education projects in San Francisco elementary schools.
Enriqueta C. Bond, president of the Burroughs Wellcome Fund, received her undergraduate degree in zoology and physiology from Wellesley College, a master's degree in biology and genetics from the University of Virginia, and a PhD in molecular biology and biochemical genetics from Georgetown University. She is a member of the American Association for the Advancement of Science, the American Society for Microbiology, and the American Public Health Association. She serves on the Board of Health Sciences Policy of the Institute of Medicine (IOM), the Board of the Society for the Advancement of Research on Women's Health, and the Board of the North Carolina Biotechnology Center. Dr. Bond was executive officer of IOM from 1989 to 1994.
Lewis M. Branscomb is the Aetna Professor of Public Policy and Corporate Management emeritus and former director of the Science, Technology, and Public Policy Program in the Center for Science and International Affairs at Harvard University's Kennedy School of Government. Dr. Branscomb graduated from Duke University in 1945, summa cum laude, and was awarded a PhD in physics by Harvard University in 1949. He has held teaching positions at the University of Maryland and the University of Colorado. He is a former president of the American Physical Society and of Sigma Xi, the Scientific Research Society. A research physicist at the National Bureau of Standards (now the National Institute of Standards and Technology) from 1951 to 1969, he was its director of NBS from 1969 to 1972. He is a member of the National Academy of Engineering, the National Academy of Sciences, and the National Academy of Public Administration. He serves on the Technology Assessment Advisory Committee to the Technology Assessment Board of the Congress. Dr. Branscomb is a former director of the IBM Europe, Middle East, Africa Corporation and of General Foods Corporation. He is a director of Mobil, MITRE, and the Lord Corporation and C. S. Draper Laboratories. He has written extensively on science and technology policy, comparative science and technology policy of different nations, information technology, management of technology, and atomic and molecular physics.
David R. Challoner is the director of the Institute for Science and Health Policy at the University of Florida. He served as vice president for health affairs and chairman of the Board of Directors of the Shands Health System at the University of Florida. He has held various profes-